Strengthens Patent Portfolio Protecting Horsepox-Based Live Virus Vaccines TNX-1840 and TNX-1850 are Potential RPV Vaccines Designed to Protect Against COVID-19 Discover Tomorrow’s Winning Stocks! Thank you for subscribing. Something went wrong. Get our latest stock … Continue reading Tonix Pharmaceuticals (NASDAQ: TNXP) Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology